513 related articles for article (PubMed ID: 19413702)
1. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
[TBL] [Abstract][Full Text] [Related]
3. Hepatic manifestations of women with polycystic ovary syndrome.
Chen MJ; Ho HN
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
[TBL] [Abstract][Full Text] [Related]
4. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
5. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
6. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
7. Adolescent polycystic ovary syndrome.
Connor EL
Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.
Romualdi D; Costantini B; Campagna G; Lanzone A; Guido M
Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and types of dyslipidemia in PCOS.
Diamanti-Kandarakis E; Papavassiliou AG; Kandarakis SA; Chrousos GP
Trends Endocrinol Metab; 2007 Sep; 18(7):280-5. PubMed ID: 17692530
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
11. PCOS: metabolic impact and long-term management.
Carmina E
Minerva Ginecol; 2012 Dec; 64(6):501-5. PubMed ID: 23232534
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
Diamanti-Kandarakis E
Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
14. Treatment of PCOS in adolescence.
Warren-Ulanch J; Arslanian S
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):311-30. PubMed ID: 16772160
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
Hillard PJ
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
[TBL] [Abstract][Full Text] [Related]
16. The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date.
Kolnikaj TS; Herman R; Janež A; Jensterle M
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399531
[TBL] [Abstract][Full Text] [Related]
17. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada R; Williams T
FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
[TBL] [Abstract][Full Text] [Related]
19. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
Szpringer EA; Lutnicki KR; Zych IS
Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
[TBL] [Abstract][Full Text] [Related]
20. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
